BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
103.15
+0.45 (0.44%)
At close: Nov 28, 2025, 4:00 PM EST
102.90
-0.25 (-0.24%)
After-hours: Nov 28, 2025, 4:15 PM EST
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
$546,192
Profits / Employee
-$99,034
Market Cap
24.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | 1,941 | 631 | 48.17% |
| Dec 31, 2019 | 1,310 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BNTX News
- 2 days ago - BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration - GlobeNewsWire
- 10 days ago - BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript - Seeking Alpha
- 14 days ago - Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up - Reuters
- 15 days ago - Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run - Benzinga
- 15 days ago - BioNTech says collaboration with Pfizer remains unchanged - Reuters
- 25 days ago - BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold - Seeking Alpha
- 25 days ago - BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership - Benzinga